PFE.BA

N/A

Pfizer Inc. — PEG Ratio Analysis

—

PEG Ratio

Negative EPS growth — PEG not meaningful when earnings are declining

—

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$9770.00

TTM EPS

$0.59

P/E Ratio

16559.32

Growth Rate

-39.1%

5-Year EPS CAGR

Sector

Healthcare

Drug Manufacturers - General

Calculated

6/17/2026

9:00:51 AM

PEG Ratio Unavailable

Negative Growth — PEG not meaningful

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.